Advanced and sustainable patient-centric healthcare

Related Material Issues
  • Creation of innovative drugs and services, powered by unique strength in science and technology
  • Provision of individualized and optimal solutions to patients
  • Access to healthcare
  • Quality assurance and stable supply of products and services
  • Safety of patients and clinical trial participants
  • Co-creation of a healthcare ecosystem with society and community

Creation of innovative drugs and services, powered by unique strength in science and technology

To realize advanced and sustainable healthcare, continuously create innovative, high-quality drugs and services that address unmet medical needs. To achieve this, we will create original technologies mainly for drug discovery, and cultivate understanding of science and biology for disease.
Based on our value of patient-centricity, we aim to provide drugs and services that are centered on patients and reduce burdens on people around them such as caregivers and healthcare professionals and improve their QOL. To this end, we will actively adopt advanced technologies such as digital technology, and continuously work together with people around world on sophistication and acceleration of business processes for value creation, collaborate with academia, open innovation, advanced use of intellectual property, etc.

Quality assurance and stable supply of products and services

To provide reliable products and services that customers can use with confidence, we will ensure consistent and stable products and services, as well as information quality, throughout the product life cycle from the clinical trial stage. We will also make efforts to prevent counterfeiting and poor quality of drugs, such as enhancing traceability in the supply chain. In addition, in accordance with the basic concept of quality, we will build a supply chain that is robust even in emergencies by working together with stakeholders in the value chain.

Provision of individualized and optimal solutions to patients

We will generate evidence that enhances value for patients, continuously working to provide solutions that meet the diverse needs of individual patients and medical practices to strengthen and advance them.
Contribute to the provision of healthcare that is optimal for each patient and truly enhances value together with stakeholders involved in healthcare such as patients, their families, and healthcare professionals.

Safety of patients and clinical trial participants

To ensure thorough management of safety throughout the product lifecycle and minimize potential negative impact such as deteriorating health to patients and clinical trial subjects. In addition to carrying out appropriate pharmacovigilance activities in cooperation with regulatory authorities, we ensure the provision of information to healthcare professionals to promote the proper use of drugs and services.
Particularly in ensuring the safety of products and conducting clinical studies on development products, risks and efficacy shall be appropriately evaluated from the viewpoints of high ethics and science.

Access to healthcare

We will contribute to regional healthcare coordination and enhancement of healthcare so that highly specialized medical care, mainly comprising innovative drugs and services that address unmet medical needs, can be delivered to people around the world who need it. We will realize continuous and sustainable creation of drugs and services by obtaining appropriate recognition for the provision of innovative drugs and services that have true value while taking measures such as cost reduction by proactive use of new technologies and promotion of treatment design with less burden for patients.

Co-creation of a healthcare ecosystem with society and community

In order to support the foundation for sustainable patient-centric and advanced healthcare, and to expand healthy society, we collaborate with various entities such as society/community, patient group, government, administration, to create collective impact against social issues related to healthcare that cannot be solved by our company alone.
Through this, we will contribute to the maintenance, expansion and development of a robust foundation and ecosystem that supports medicine and healthcare as a leader in the industry.